Your browser doesn't support javascript.
loading
Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
Harris, William P; Wong, Kit Man; Saha, Supriya; Dika, Imane El; Abou-Alfa, Ghassan K.
Afiliação
  • Harris WP; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA.
  • Wong KM; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA.
  • Saha S; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle WA; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle WA.
  • Dika IE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Medical College at Cornell University, New York, NY. Electronic address: abou-alg@mskcc.org.
Semin Oncol ; 45(3): 116-123, 2018 06.
Article em En | MEDLINE | ID: mdl-30348531

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Biomarcadores Tumorais / Carcinoma Hepatocelular / Terapia de Alvo Molecular / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Biomarcadores Tumorais / Carcinoma Hepatocelular / Terapia de Alvo Molecular / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article